Solid composition comprising pcsk9 inhibitor and salt of n-(8-(2-hydroxybenzoyl) amino) caprylic acid

The present invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF (A) peptide and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid. The invention further relates to a process for the preparation of such a composition, and to the use thereof in medicine....

Full description

Saved in:
Bibliographic Details
Main Authors VIGH ANDRAS, LABEQUE ULLA LODEWIJK, BJERREGAARD, STEN, WATT, JAMES, J, NERAPPA KIRAN, SARSON, PAUL, J
Format Patent
LanguageChinese
English
Published 17.06.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF (A) peptide and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid. The invention further relates to a process for the preparation of such a composition, and to the use thereof in medicine. 本发明涉及包含PCSK9抑制剂如EGF(A)肽和N-(8-(2-羟基苯甲酰基)氨基)辛酸的盐的药物组合物。本发明进一步涉及这类组合物的制备方法，及其在医学中的用途。
Bibliography:Application Number: CN202080077367